By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anika Therapeutics 

32 Wiggins Avenue

Bedford  Massachusetts  01730   U.S.A.
Phone: 781-457-9000 Fax: 781-935-4120

Anika Therapeutics is a pioneer in developing therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. HA also is present in the skin, where it supports skin structure and elasticity. With more than 20 years of experience in HA technology, Anika is recognized worldwide as a provider of premium HA products that are effective, safe and long-lasting.

Anika manufactures and distributes a diverse portfolio of HA-based products that cover a broad range of therapeutic applications. These products include ORTHOVISC®, ORTHOVISC® mini, and MONOVISC™ used in the treatment of osteoarthritis; HYVISC® used in the treatment of equine osteoarthritis; the ELEVESS™ family of cosmetic dermatology products for facial wrinkles, scar remediation and lip augmentation; AMVISC®, AMVISC® Plus, STAARVISC™ II, and OPTIVISC™ injectable viscoelastic HA products for ophthalmic surgery; INCERT®, an HA-based anti-adhesive for surgical applications; and next-generation products for joint health and aesthetic dermatology based on the Company's proprietary, chemically modified HA.

Key Statistics

Ownership: Public

Web Site: Anika Therapeutics
Symbol: ANIK


Company News
Anika Therapeutics (ANIK)' Cingal 13-02 Study Meets Primary Endpoint 4/20/2015 6:42:43 AM
Anika Therapeutics (ANIK) Reports On Cingal 13-01 Study Clinical Trial Top Line Data And Announces The Completion Of Cingal 13-02 Study’s Patient Enrollment 4/17/2015 8:56:29 AM
Anika Therapeutics (ANIK) Announces Date Of First-Quarter 2015 Financial Results Conference Call 4/16/2015 12:31:03 PM
Anika Therapeutics (ANIK) Release: Hyalomatrix Receives CMS Reimbursement Coverage In 11 States 4/13/2015 11:36:41 AM
Anika Therapeutics (ANIK) Files IDE Application With U.S. FDA For Hyalofast 4/9/2015 9:25:33 AM
Anika Therapeutics (ANIK) To Present At Canaccord Genuity Musculoskeletal Conference March 24 3/18/2015 9:53:17 AM
Anika Therapeutics (ANIK) Reports Fourth-Quarter And Full-Year 2014 Financial Results 2/26/2015 11:38:37 AM
Anika Therapeutics (ANIK) Appoints Dr. Glenn Larsen To Its Board Of Directors 2/20/2015 11:11:48 AM
Anika Therapeutics (ANIK) Announces Date Of Fourth-Quarter And Year-End 2014 Financial Results Conference Call 2/13/2015 10:04:18 AM
Anika Therapeutics (ANIK) Announces Regulatory Submissions With U.S. FDA And European Regulatory Authorities For Cingal 2/12/2015 11:49:58 AM